Similar articles

• Calcium carbonate in hyperphosphatemia.

  Mayo M, Middleton RK. Mayo M, et al. DICP. 1991 Sep;25(9):945-7. DICP. 1991. PMID: 1949973 Review. No abstract available.
• [Methods of correcting hyperphosphatemia in chronic renal failure and in dialysis (review)].

  Novikov AI. Novikov AI. Ter Arkh. 1997;69(12):63-7. Ter Arkh. 1997. PMID: 9503540 Review. Russian. No abstract available.
• Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.

  Janssen MJ, van der Kuy A, ter Wee PM, van Boven WP. Janssen MJ, et al. Clin Nephrol. 1996 Feb;45(2):111-9. Clin Nephrol. 1996. PMID: 8846523 Clinical Trial.
• Risk factors in aluminum toxicity in children with chronic renal failure.

  Santos F, Massie MD, Chan JC. Santos F, et al. Nephron. 1986;42(3):189-95. doi: 10.1159/000183665. Nephron. 1986. PMID: 3511396 Review. No abstract available.
• Calcium carbonate as an alternative to aluminium hydroxide in maintenance haemodialysis for chronic renal failure.

  O'Brien A, McParland C, Keogh B. O'Brien A, et al. Ir Med J. 1987 Feb;80(2):68-70. Ir Med J. 1987. PMID: 3557928 No abstract available.